Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07059884 · ClinicalTrials.gov registry record · NA

Distance-Based Exercise to Preserve Function and Prevent Disability

A NA study of Hematopoietic and Lymphatic System Neoplasm and Localized Malignant Solid Neoplasm, sponsored by Alliance for Clinical Trials in Oncology.

Recruiting
Registry status
NA
Development phase
104
Enrollment target
14
Study locations

NCT07059884 is a NA study of Hematopoietic and Lymphatic System Neoplasm and Localized Malignant Solid Neoplasm that is actively recruiting participants, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 104 participants, below the 481-participant average among 62 other Hematopoietic and Lymphatic System Neoplasm trials with a reported enrollment target (78% lower). The trial reports 14 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07059884, a NA study of Hematopoietic and Lymphatic System Neoplasm and Localized Malignant Solid Neoplasm, is actively recruiting participants, sponsored by Alliance for Clinical Trials in Oncology.

RECRUITING
Registry status
NA
Development phase
104 participants
Enrollment target
14
Study locations

Study Summary

This clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to exercise in their own home. Treatments for cancer can cause side effects such as fatigue and loss of strength. These side effects can make it difficult to work, take care of family, and do other things the patient wants to do. Preliminary research shows that exercise can help prevent some of these side effects, but it can be more difficult to start an exercise program when a patient is receiving cancer treatment. The exercise program in this study is delivered through telehealth (TH) video calls. The TH sessions are delivered by trained staff that supervise resistance exercises. The trained staff also provide guidance to the patient on completing unsupervised aerobic sessions on their own. This may be a successful way to deliver an exercise program and make it easier for cancer patients to exercise in their own home during treatment.

Interventions

  • OTHER Telemedicine
  • PROCEDURE Accelerometry
  • OTHER Exercise intervention
  • OTHER Aerobic Exercise Intervention
  • OTHER Dumbbell Exercise Intervention

Study Locations (14)

California

  • Kaiser Permanente Dublin - Dublin
  • Kaiser Permanente-Fremont - Fremont
  • Kaiser Permanente Fresno Orchard Plaza - Fresno
  • Kaiser Permanente-Modesto - Modesto
  • Kaiser Permanente-Oakland - Oakland
  • Kaiser Permanente-South Sacramento - Sacramento
  • Kaiser Permanente-Santa Teresa-San Jose - San Jose
  • Kaiser San Rafael-Gallinas - San Rafael
  • Kaiser Permanente-Vallejo - Vallejo

Pennsylvania

  • UPMC Hillman Cancer Center at Butler Health System - Butler
  • IRMC Cancer Center - Indiana
  • UPMC Hillman Cancer Center - New Castle - New Castle
  • UPMC Cancer Center at UPMC Northwest - Seneca

Massachusetts

  • Dana-Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2026-02-11
Est. Completion 2027-02-18
Phase NA

What the Registry Record Tells You About NCT07059884

The ClinicalTrials.gov registry entry for NCT07059884 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 481-participant average among 62 other Hematopoietic and Lymphatic System Neoplasm trials with a reported enrollment target (78% lower). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hematopoietic and Lymphatic System Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Telemedicine is the first listed.

NCT07059884 reports 14 study locations spanning 3 distinct geographic areas - top geographies include California, Pennsylvania, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07059884 about?

NCT07059884 is a clinical study titled "Distance-Based Exercise to Preserve Function and Prevent Disability". This clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to exercise in their own home. Treatments for cancer can cause side effects such as fatigue and loss of strength. These side ef...

What is the current status of trial NCT07059884?

This trial is currently recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2026-02-11. Estimated completion is 2027-02-18.

What conditions does trial NCT07059884 study?

This clinical trial studies the following conditions: Hematopoietic and Lymphatic System Neoplasm, Localized Malignant Solid Neoplasm.

What interventions are being tested in trial NCT07059884?

The interventions under investigation include: Telemedicine (OTHER), Accelerometry (PROCEDURE), Exercise intervention (OTHER), Aerobic Exercise Intervention (OTHER), Dumbbell Exercise Intervention (OTHER).

Who is sponsoring clinical trial NCT07059884?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07059884 being conducted?

This trial has 14 study locations across California, Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hematopoietic and Lymphatic System Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.